We've found
184,457
clinical trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Assisted Exercise in Obese Endometrial Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)
Status: Enrolling,
Phase
II
Updated: 4/27/2016
Click here to add this to my saved trials
Other Clinical Trial
A Study to Evaluate Aprepitant for the Prevention of Post Operative Nausea and Vomiting in Children (MK-0869-219)
Status: Enrolling,
Phase
II
Updated: 6/9/2016
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Transtibial Amputation Clinical Trial
Transtibial Amputation Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Residual Neuromuscular Blockade Clinical Trial
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
We've found
184,457
clinical trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Updated: 12/31/1969
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Updated: 4/17/2014
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Updated: 4/17/2014
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Assisted Exercise in Obese Endometrial Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-289)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Fatigue Clinical Trial
Updated: 12/31/1969
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myelogenous Leukemia Clinical Trial
Updated: 12/31/1969
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neoplasms Clinical Trial
Updated: 12/31/1969
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
Updated: 12/31/1969
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chemotherapy-Induced Nausea and Vomiting Clinical Trial
Updated: 4/27/2016
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)
Status: Enrolling,
Phase
II
Updated: 4/27/2016
Click here to add this to my saved trials
Other Clinical Trial
Updated: 6/9/2016
A Study to Evaluate Aprepitant for the Prevention of Post Operative Nausea and Vomiting in Children (MK-0869-219)
Status: Enrolling,
Phase
II
Updated: 6/9/2016
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Osteoporosis Clinical Trial
Updated: 8/28/2014
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Transtibial Amputation Clinical Trial
Updated: 12/31/1969
Transtibial Amputation Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
Updated: 12/31/1969
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Residual Neuromuscular Blockade Clinical Trial
Updated: 12/31/1969
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials